Shukra Pharmaceuticals Ltd Share Price

28.75

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 06-Aug-2019 - -
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2019 ,inter alia, to consider and approve unaudited financial result for the quarter ended on June, 2019 and other agenda as mentioned in the notice of the meeting of Board of Directors of the Company attached herewith. Wrt above sub and in compliance with Regulation 30 of the Securities and Exchange Board of India (LODR) Regulations, 2015, we hereby submit the outcome of the Meeting of the BoD held on today at 11:00 a.m. and concluded on 11.30 p.m. 1)Considered, adopted and approved Unaudited Fin. Results for the qtr ended on 30th June, 2019. 2) The AGM will be held on Friday, 27th September, 2019 at 02:00 p.m. at the regd office of the company. 3)The Register of Members & Share Transfer Books of the Company will remain closed from 23rd September, 2019 to 27th September, 2019 (both days inclusive) for the purpose of AGM of the Company. 4)Approval and adoption of Directors Report for the year ended March 31, 2019. 5)Approval and adoption of notice for AGM. 6)Appointment of Mrs. Rupal Patel, Practicing Company Secretary as Scrutinizer for the process of Remote E-voting as well as voting at the AGM. (As Per BSE Announcement Dated 14.08.2019)
Board Meeting - 08-Jul-2019 - -
Shukra Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Director of the Company will be held on July 15, 2019, inter alia, to transact the following business :- To declare dividend for FY 2018-19. With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on 15th July, 2019 at 01:00 p.m. and concluded on 02:00 p.m. 1) Board of Directors has recommended a dividend @ Rs. 0.50/- per Equity Shares, i.e. 5 % on Equity Shares subject to approval of members at the ensuing Annual General Meeting. 2) Acceptance of resignation of Ms. Bhoomika Vasavani from the post of Company Secretary of the Company. 3) Reviewed business of the Company. Please take the same on record. (As Per BSE Announcement Dated on 16.07.2019)
Board Meeting - 21-May-2019 - -
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve 1. To Consider adopt and approve audited financial result for the quarter and year ended on 31st March, 2019. 2. To adopt Secretarial Audit Report for Financial Year 2018-19 3. To accept resignation of Mr. Karnik Shah from the post of CFO of the Company 4. To appoint Mr. Karnik Shah as a CEO of the Company 5. Any other business with the permission of the Chair. With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 28th May, 2019 at 01:00 p.m. and concluded on 07:00 p.m. 1) Considered, adopted and approved Audited Financial Results for the quarter and year ended on 31st March, 2019. 2) Adoption of Secretarial Audit Report for Financial Year 2018-19 3) The Board accepted resignation of Mr. Karnik Shah from the post of CFO of the Company. 4) Appointment of Mr. Karnik Shah as a CEO of the Company. 5) Reviewed business of the Company (As Per BSE Announcement Dated on 28/05/2019)
Board Meeting - 30-Apr-2019 - -
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2019 ,inter alia, to consider and approve 1. To accept resignation of Ms. Payal Mehta from the post of CFO of the Company. 2. To appoint Mr. Karnik Shah as a CFO of the Company. 3. Any other business with the permission of the Chair. With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 03rd May, 2019 at 01:00 p.m. and concluded on 03:00 p.m. 1) Acceptance of resignation of Ms. Payal Mehta from the post of Chief Financial Officer (CFO) of the Company. 2) Appointment of Mr. Karnik Shah as Chief Financial Officer (CFO) of the Company. (As Per BSE Announcement Dated on 02.05.2019)
Board Meeting - 06-Apr-2019 - -
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/04/2019 ,inter alia, to consider and approve 1. To appoint Ms. Rupal Patel, Practising Company Secretary as Secretarial Auditor of the Company for the F.Y. 2018-19. 2. Any other business with the permission of the Chair. With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 13th April, 2019 at 01:00 p.m. and concluded on 06.45 p.m. 1) Appointment of Ms. Rupal Patel, Practising Company Secretary as Secretarial Auditor of the Company for the F.Y. 2018-19. 2) Acceptance of resignation of Ms. Payal Mehta from the post of Chief Executive Officer (CEO) of the Company. 3) Appointment of Ms. Payal Mehta as Chief Financial Officer (CFO) of the Company. (As Per BSE Announcement Dated 13.04.2019)
Board Meeting - 07-Mar-2019 - -
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/03/2019 ,inter alia, to consider and approve 1) To review the performance of Non-Independent Directors and the Board as a whole. 2) To Review the performance of the Chairman of the Company. 3) To access the Quantity, Quality and timeliness of flow of information. 4) Any other business with the permission of the chair. 1.Independent Directors of the company has reviewed performance of Non-Independent Directors, Board and Chairman of the Company. 2.Evaluate the access of the Quantity, Quality and timeliness of flow of information. (As Per BSE Announcement Dated 16.03.2019)
Board Meeting - 05-Feb-2019 - -
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2019 ,inter alia, to consider and approve 1. To consider, adopt and approve Unaudited Financial Results for the quarter ended on 31st December, 2018. 2. To consider and accept the resignation tendered by the following Director: a) Sonal Chandreshkumar Patel b) Chandreshbhai Dasarathlal Patel 3. To accept resignation of Mr. Sujay Mehta from the post of CFO of the Company. 4. Any other business with the permission of the Chair. With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 13th February, 2019 at 01:00 p.m. and concluded on 8.50 p.m. 1) Considered, adopted and approved Unaudited Financial Results for the quarter ended on 31st December, 2018. 2) The Board accepted and noted the resignation tendered by the following Independent Directors: a) Sonal Chandreshkumar Patel b) Chandreshbhai Dasarathlal Pate 3) The Board accepted resignation of Mr. Sujay Mehta from the post of CFO of the Company. Please take the same on record. Thanking you, Yours faithfully For Shukra Pharmaceuticals Limited Dakshesh Shah Director DIN: 0561666 With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 13th February, 2019 at 01:00 p.m. and concluded on 8.50 p.m. 1) Considered, adopted and approved Unaudited Financial Results for the quarter ended on 31st December, 2018. 2) The Board accepted and noted the resignation tendered by the following Independent Directors: a) Sonal Chandreshkumar Patel b) Chandreshbhai Dasarathlal Pate 3) The Board accepted resignation of Mr. Sujay Mehta from the post of CFO of the Company. Please take the same on record. Thanking you, Yours faithfully For Shukra Pharmaceuticals Limited Dakshesh Shah Director DIN: 0561666 (As Per BSE Announcement Dated 13.02.2019) With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 13th February, 2019 at 01:00 p.m. and concluded on 8:50 p.m. 1) Considered, adopted and approved Unaudited Financial Results for the quarter ended on 31st December, 2018. 2) The Board accepted and noted the resignation tendered by the following Independent Directors: a) Sonal Chandreshkumar Patel b) Chandreshbhai Dasarathlal Pate 3) The Board accepted resignation of Mr. Sujay Mehta from the post of CFO of the Company. (As Per BSE Announcement Dated On 22/02/2019)
Board Meeting - 07-Jan-2019 - -
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/01/2019 ,inter alia, to consider and approve 1. To appoint Mr. Nileshkumar Patel (DIN: 08316887) as an additional Director. 2. To appoint Ms. Bhoomiben Patel (DIN: 08316893) as an additional Director. 3. Any other business with the permission of the Chair. With reference to above subject and in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Meeting of the Board of Director held on today i.e. 16th January, 2019 at 02:00 p.m. and concluded on 04.00 p.m. 1) Appointment of Mr. Nileshkumar Patel (DIN: 08316887) as an additional Director of the Company. 2) Appointment of Ms. Bhoomiben Patel (DIN: 08316893) as an additional Director of the Company. (As Per BSE Announcement Dated On 19/01/2019)
Board Meeting - 02-Nov-2018 - -
SHUKRA PHARMACEUTICALS LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve 1. To consider, adopt and approve Unaudited Financial Results for the quarter ended on 30th September, 2018. 2. Any other business with the permission of the Chair. we hereby submit the outcome of the Meeting of the Board of Director held on today i.e 14th November, 2018 at 03:00 p.m. and concluded on 7.15 p.m. 1) Considered, adopted and approved Unaudited Financial Results for the quarter and half year ended on 30th September, 2018. , we hereby submit the outcome of the Meeting of the Board of Director held on today i.e 14th November, 2018 at 03:00 p.m. and concluded on 7.15 p.m. 1) Considered, adopted and approved Unaudited Financial Results for the quarter and half year ended on 30th September, 2018 (As Per BSE Announcement Dated on 14.11.2018)